Treatment failures secondary to drug interactions with divalent cations and fluoroquinolone

被引:11
作者
Garey, KJ
Suda, KW
Danziger, LH
机构
[1] Univ Houston, Coll Pharm, Dept Clin Sci & Adm, Houston, TX 77030 USA
[2] Univ Illinois, Coll Pharm, Dept Pharm Practice, Chicago, IL USA
来源
PHARMACY WORLD & SCIENCE | 2005年 / 27卷 / 02期
关键词
antacids; ciprofloxacin; divalent cations; drug interactions; fluoroquinolones; levofloxacin;
D O I
10.1007/s11096-004-7040-0
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
We observed four cases of therapeutic failures while patients were simultaneously taking medications that contained divalent cations and oral fluoroquinolones. Patients improved after conversion to the intravenous formulation of the same antibiotics, proper spacing of the divalent cation, or conversion to a different antibiotic class. Patients prescribed oral fluoroquinolones should receive instructions on proper separations of these antibiotics with divalent cations. Health care professionals should be cognizant of these interactions and educated on their potential deleterious effect.
引用
收藏
页码:81 / 82
页数:2
相关论文
共 12 条
[1]   EFFECTS OF ALUMINUM HYDROXIDE AND CALCIUM-CARBONATE ANTACIDS ON THE BIOAVAILABILITY OF CIPROFLOXACIN [J].
FROST, RW ;
LASSETER, KC ;
NOE, AJ ;
SHAMBLEN, EC ;
LETTIERI, JT .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1992, 36 (04) :830-832
[2]  
GAREY K, 2000, DRUG INTERACTIONS IN
[3]   SUCRALFATE SIGNIFICANTLY REDUCES CIPROFLOXACIN CONCENTRATIONS IN SERUM [J].
GARRELTS, JC ;
GODLEY, PJ ;
PETERIE, JD ;
GERLACH, EH ;
YAKSHE, CC .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1990, 34 (05) :931-933
[4]   CLINICAL AND CHEMICAL INTERACTIONS BETWEEN IRON PREPARATIONS AND CIPROFLOXACIN [J].
KARA, M ;
HASINOFF, BB ;
MCKAY, DW ;
CAMPBELL, NRC .
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1991, 31 (03) :257-261
[5]   Effects of food and sucralfate on a single oral dose of 500 milligrams of levofloxacin in healthy subjects [J].
Lee, LJ ;
Hafkin, B ;
Lee, ID ;
Dix, R .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1997, 41 (10) :2196-2200
[6]   Pharmacokinetics of gatifloxacin and interaction with an antacid containing aluminum and magnesium [J].
Lober, S ;
Ziege, S ;
Rau, M ;
Schreiber, G ;
Mignot, A ;
Koeppe, P ;
Lode, H .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1999, 43 (05) :1067-1071
[7]   Pharmacokinetic interactions related to the chemical structures of fluoroquinolones [J].
Mizuki, Y ;
Fujiwara, I ;
Yamaguchi, T .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1996, 37 :41-55
[8]   EFFECTS OF ALUMINUM AND MAGNESIUM ANTACIDS AND RANITIDINE ON THE ABSORPTION OF CIPROFLOXACIN [J].
NIX, DE ;
WATSON, WA ;
LENER, ME ;
FROST, RW ;
KROL, G ;
GOLDSTEIN, H ;
LETTIERI, J ;
SCHENTAG, JJ .
CLINICAL PHARMACOLOGY & THERAPEUTICS, 1989, 46 (06) :700-705
[9]  
NIX DE, 1989, PHARMACOTHERAPY, V9, P377
[10]   Lack of bioequivalence of gatifloxacin when coadministered with calcium-fortified orange juice in healthy volunteers [J].
Wallace, AW ;
Victory, JM ;
Amsden, GW .
JOURNAL OF CLINICAL PHARMACOLOGY, 2003, 43 (01) :92-96